G43.909

Migraine, unspecified, not intractable, without status migrainosus

G43.909 is a clinical classification for a migraine headache where the specific subtype (such as migraine with or without aura) has not been clinically determined or documented. This diagnosis is specifically reserved for cases designated as 'not intractable,' meaning the condition typically responds to standard abortive or preventive treatments and does not meet the criteria for being pharmacologically resistant. Furthermore, it is classified as 'without status migrainosus,' indicating that the individual attack does not exceed 72 hours in duration and is not considered a debilitating, continuous episode. Migraines are neurovascular disorders characterized by recurrent, moderate-to-severe headaches often associated with autonomic symptoms and sensory sensitivities.

Clinical Symptoms

Unilateral head pain (often affecting one side)
Pulsating or throbbing pain quality
Moderate to severe pain intensity
Nausea
Vomiting
Photophobia (sensitivity to light)
Phonophobia (sensitivity to sound)
Osmophobia (sensitivity to odors)
Aggravation by routine physical activity
Blurred vision
Lightheadedness or dizziness

Common Causes

Genetic predisposition and family history
Hormonal fluctuations (especially estrogen changes in women)
Environmental triggers (bright lights, loud noises, strong smells)
Stress and emotional tension
Sleep disturbances or changes in sleep patterns
Dietary triggers (e.g., aged cheeses, MSG, nitrates, artificial sweeteners)
Alcohol consumption (particularly red wine)
Caffeine withdrawal or excessive intake
Sensitization of the trigeminal nerve system
Changes in brainstem activity and neurotransmitter imbalances (e.g., serotonin)

Documentation & Coding Tips

Distinguish between with and without aura to improve specificity from unspecified codes.

Example: Patient reports recurring unilateral, throbbing headaches. Patient denies any focal neurological symptoms, visual scotoma, or tingling preceding the onset of pain, effectively ruling out aura. Symptoms are currently controlled with PRN ibuprofen, indicating the condition is not intractable. The diagnosis is migraine without aura, not intractable, without status migrainosus (G43.009), which provides higher specificity than the unspecified G43.909 code.

Billing Focus: Documenting the presence or absence of aura is a primary requirement for moving beyond the unspecified G43.9 level to more specific G43.0 or G43.1 codes.

Explicitly state the absence of status migrainosus for every migraine encounter.

Example: The current episode began 6 hours ago and is of moderate intensity. Patient denies a continuous headache lasting more than 72 hours. This confirms the absence of status migrainosus. Patient has a history of MDD (F33.1), which is monitored as a comorbidity affecting pain perception.

Billing Focus: The sixth character of the ICD-10 code (9 in G43.909) specifically denotes that the patient is not experiencing a prolonged attack of 72 hours or more.

Clearly define intractability based on the patient response to treatment.

Example: Patient is experiencing 3-4 migraine days per month. The headaches are successfully terminated using oral triptans within 2 hours of onset. Because the patient does not demonstrate a failure of at least two classes of acute or preventive medications, the condition is documented as not intractable. This supports the use of the fifth character 0 in G43.909.

Billing Focus: Clinical documentation must define if the patient is refractory to treatment to distinguish between G43.909 and G43.919.

Document frequency of attacks to differentiate episodic from chronic migraine.

Example: Patient has had 8 headache days over the last 30 days, 4 of which met migraine criteria. This frequency (below 15 days per month) confirms episodic rather than chronic migraine. No status migrainosus or intractability noted. Ongoing tobacco use (Z72.0) is identified as a modifiable risk factor.

Billing Focus: Chronicity is a major axis of the G43 category; documenting the number of headache days per month is essential for coding accuracy.

Record the laterality and location of the headache pain.

Example: Patient describes current headache as strictly right-sided, supraorbital, and pulsating. This lateralized presentation is characteristic of migraine. There is no evidence of medication overuse headache (G44.40). The condition is currently not intractable and without status migrainosus.

Billing Focus: While laterality is not a direct character in G43.909, it supports the clinical validity of the migraine diagnosis over other headache types.

Relevant CPT Codes

99203 - Office New Patient Low MDM
Commonly used for an initial assessment of stable migraine where the diagnostic pathway is straightforward.
99204 - Office New Patient Moderate MDM
Used when the new patient has multiple comorbidities or requires a complex review of prior imaging and treatments.
99213 - Office Established Patient Low MDM
Typical for a follow-up visit where the patient is responding well to medication and no new concerns are raised.
99214 - Office Established Patient Moderate MDM
Appropriate when adjusting prophylaxis medications or addressing worsening symptoms in a known migraine patient.
96372 - Therapeutic Injection Subcutaneous or Intramuscular
Used for the administration of acute migraine medications like sumatriptan or ketorolac in the office.
90785 - Interactive Complexity
Used when the clinical interview is complicated by communication barriers, often seen in comorbid psychiatric conditions.
64405 - Greater Occipital Nerve Block
A common procedure for patients whose migraines are not fully controlled by oral medications.
95819 - EEG Awake and Asleep
Used to rule out seizure disorders if the migraine presentation involves atypical neurological features.
99441 - Phone Evaluation 5-10 Min
Used for quick follow-ups on medication side effects or dosage adjustments.
20550 - Injection Single Tendon Sheath
Sometimes used in conjunction with myofascial trigger point injections for migraine associated with neck pain.